<VariationArchive RecordType="classified" VariationID="11637" VariationName="NG_011641.2:g.(108110_108560)_(109645_112963)del" VariationType="Deletion" Accession="VCV000011637" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-02" DateCreated="2017-06-20" MostRecentSubmission="2017-06-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26676" VariationID="11637">
      <GeneList>
        <Gene Symbol="SLC16A2" FullName="solute carrier family 16 member 2" GeneID="6567" HGNC_ID="HGNC:10923" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74421493" stop="74533916" display_start="74421493" display_stop="74533916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73641327" stop="73753763" display_start="73641327" display_stop="73753763" Strand="+" />
          </Location>
          <OMIM>300095</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_011641.2:g.(108110_108560)_(109645_112963)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.2</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>2.4-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011641.2" sequenceAccession="NG_011641" sequenceVersion="2" change="g.(108110_108560)_(109645_112963)del">
            <Expression>NG_011641.2:g.(108110_108560)_(109645_112963)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(74524359_74524809)_(74525894_74529212)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(74524359_74524809)_(74525894_74529212)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006517.5" sequenceAccession="NM_006517" sequenceVersion="5" change="c.(576_1026)_(1170+1_1171-1)del" MANESelect="true">
            <Expression>NM_006517.5:c.(576_1026)_(1170+1_1171-1)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415024" DB="dbVar" />
        <XRef ID="nsv513796" DB="dbVar" />
        <XRef Type="Allelic variant" ID="300095.0006" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 300095.0006 based on the annotation of exons in NG_011641.2.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_011641.2:g.(108110_108560)_(109645_112963)del AND Allan-Herndon-Dudley syndrome" Accession="RCV000012403" Version="16">
        <ClassifiedConditionList TraitSetID="3177">
          <ClassifiedCondition DB="MedGen" ID="C0795889">Allan-Herndon-Dudley syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-06-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-06-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-06-20" MostRecentSubmission="2017-06-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Friesema, E., Grueters, A., Halestrap, A., Reeser, M., Visser, T. Mutations in a thyroid hormone transporter in patients with severe psychomotor retardation and high serum T3 levels. (Abstract) Thyroid 13: 672-only, 2003.</CitationText>
        </Citation>
        <ConditionList>
          <TraitSet ID="3177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Allan-Herndon syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Monocarboxylate transporter-8 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TRIIODOTHYRONINE RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Triiodothyronine resistence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 resisitence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation with hypotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation and muscular atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Allan-Herndon-Dudley syndrome</ElementValue>
                <XRef ID="Allan-Herndon-Dudley+Syndrome/306" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010354" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AHDS</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5617" />
                <XRef ID="5617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Allan-Herndon-Dudley syndrome (AHDS), an X-linked disorder, is characterized in males by neurologic findings (hypotonia and feeding difficulties in infancy, developmental delayÂ / intellectual disability ranging from mild to profound) and later-onset pyramidal signs, extrapyramidal findings (dystonia, choreoathetosis, paroxysmal movement disorder, hypokinesia, masked facies), and seizures, often with drug resistance. Additional findings can include dysthyroidism (manifest as poor weight gain, reduced muscle mass, and variable cold intolerance, sweating, elevated heart rate, and irritability) and pathognomonic thyroid test results. Most heterozygous females are not clinically affected but may have minor thyroid test abnormalities.</Attribute>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301789</ID>
                <ID Source="BookShelf">NBK26373</ID>
              </Citation>
              <XRef ID="59" DB="Orphanet" />
              <XRef ID="C0795889" DB="MedGen" />
              <XRef ID="MONDO:0010354" DB="MONDO" />
              <XRef Type="MIM" ID="300523" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32637" SubmissionDate="2017-06-15" DateLastUpdated="2017-06-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300095.0006_ALLAN-HERNDON-DUDLEY SYNDROME" title="SLC16A2, 2.4-KB DEL_ALLAN-HERNDON-DUDLEY SYNDROME" />
        <ClinVarAccession Accession="SCV000032637" DateUpdated="2017-06-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with elevated serum T3 and severe mental retardation (AHDS; 300523), Friesema et al. (2004) identified a 2.4-kb deletion in the MCT8 gene, consisting of part of exon 3, all of intron 3 and exon 4, and part of intron 4.</Attribute>
              <Citation>
                <CitationText>Friesema, E., Grueters, A., Halestrap, A., Reeser, M., Visser, T. Mutations in a thyroid hormone transporter in patients with severe psychomotor retardation and high serum T3 levels. (Abstract) Thyroid 13: 672-only, 2003.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="300523" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC16A2" />
          </GeneList>
          <Name>SLC16A2, 2.4-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2.4-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300095.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALLAN-HERNDON-DUDLEY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32637" TraitType="Disease" MappingType="Name" MappingValue="ALLAN-HERNDON-DUDLEY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0795889" Name="Allan-Herndon-Dudley syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

